Research programme: rabies vaccine - MedicagoAlternative Names: Rabies VLP vaccine - Medicago
Latest Information Update: 17 Feb 2014
At a glance
- Originator Medicago
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Rabies
Most Recent Events
- 18 Sep 2013 Medicago has been acquired by Mitsubishi Tanabe Pharma Corporation
- 20 Jan 2012 Preclinical trials in Rabies in Canada (unspecified route)